Related Experiment Video
Updated: Jun 20, 2026
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
Takayuki Kasai1, Kenjiro Bandow, Hiraku Suzuki
1Department of Oral Biochemistry, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Journal of Cellular Physiology
|September 3, 2009
Summary
AMP-activated protein kinase (AMPK) activity decreases during osteoblast differentiation. Inhibiting AMPK, using glucose restriction or metformin, impairs bone formation and mineralization, highlighting AMPK
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoblasts, derived from mesenchymal stem cells, are crucial for bone formation and mineralization.
- Runt-related transcription factor 2 (Runx2) is essential for osteoblast differentiation, but cytoplasmic signaling pathways remain unclear.
- AMP-activated protein kinase (AMPK) regulates cellular energy, polarity, and division, with its activity controlled by upstream kinases like LKB1.
Purpose of the Study:
- To investigate the role of AMPK in osteoblast differentiation using in vitro models.
- To determine the relationship between AMPK activity and the process of osteoblastic differentiation and mineralization.
Main Methods:
- In vitro culture of primary osteoblasts and MC3T3-E1 cells.
- Assessment of AMPKalpha phosphorylation levels during osteoblast differentiation.
- Inhibition of osteoblast differentiation and matrix mineralization using glucose restriction and metformin.
- Forced expression of a constitutively active form of AMPKalpha.
- Analysis of gene expression for Runx2 and osteoblast differentiation markers (Osteocalcin, Bone Sialoprotein, Osteopontin).
Main Results:
- AMPKalpha phosphorylation significantly decreased during osteoblastic differentiation in both primary osteoblasts and MC3T3-E1 cells.
- Glucose restriction and metformin, AMPK activators, significantly inhibited matrix mineralization in both cell types.
- Forced expression of active AMPKalpha also inhibited matrix mineralization.
- Metformin treatment suppressed gene expression of Runx2 and differentiation markers (Ocn, Bsp, Opn).
Conclusions:
- Osteoblast differentiation is functionally linked to decreased AMPK activity.
- AMPK activation inhibits key processes in osteoblast differentiation, including Runx2 expression and matrix mineralization.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...